Chemical & MaterialTop Companies
Chemical & Material

Top Animal Medical Devices Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Chemical & Material

Published

Jan 2026

Share:

Chemical & Material

Top Animal Medical Devices Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
3.90 Billion
2026 Forecast (US$)
4.23 Billion
2032 Forecast (US$)
6.81 Billion
CAGR (2025-2032)
8.40%

Summary

The global animal medical devices market is entering a sustained expansion phase, propelled by companion animal humanization, livestock productivity demands, and stricter safety standards. Leading players consolidate share through connected monitoring, minimally invasive tools, and integrated service offerings. From US$ 3.90 Billion in 2025, the market is projected to reach US$ 6.81 Billion by 2032, reflecting an 8.40% CAGR.

2025 Revenue of Top Animal Medical Devices Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

Rankings of Animal Medical Devices market companies are derived from a composite scoring model combining quantitative and qualitative indicators. Core metrics include 2025 animal medical device revenue, multi-year growth, and geographic diversification. We assess project wins, installed base in clinics and hospitals, and share in high-value segments such as infusion, monitoring, imaging, and surgical tools. Technology differentiation covers connectivity, data analytics, miniaturization, and evidence of regulatory compliance. Portfolio breadth, aftermarket service coverage, and ability to deliver long-term maintenance and training contracts materially influence scores. Strategic factors include partnership networks, M&A activity, innovation pipelines, and responsiveness to evolving animal welfare and biosecurity regulations. Each company receives weighted scores across these dimensions, benchmarked against global peers. Final ranks reflect overall competitive strength and forward-looking capability rather than absolute revenue alone.

Top 10 Companies in Animal Medical Devices

1
Zoetis Inc.
North America, Europe, Asia Pacific
Parsippany, USA
Companion animal monitoring, infusion pumps, diagnostic instruments, surgical devices
18.50%
Expanded connected monitoring platform, acquired niche surgical tools maker, deepened distribution in China and Brazil
US$ 720.00 Million
2
IDEXX Laboratories, Inc.
North America, Western Europe, Oceania
Westbrook, USA
In-clinic diagnostic analyzers, imaging systems, practice management integration
16.40%
Launched AI-driven imaging upgrades, expanded subscription-based hardware-as-a-service model
US$ 640.00 Million
3
Covetrus (Animal Health Device Segment)
North America, Europe
Portland, USA
Clinic equipment, anesthesia machines, monitoring, dental systems
10.50%
Strengthened private-label device portfolio, integrated logistics and financing solutions for clinics
US$ 410.00 Million
4
Dechra Pharmaceuticals PLC
Europe, North America
Northwich, United Kingdom
Veterinary surgery instruments, infusion and pain management systems
6.70%
Invested in smart infusion technologies, expanded training services for veterinary surgeons
US$ 260.00 Million
5
IMV Technologies Group
Europe, Latin America, Asia
L'Aigle, France
Reproductive devices, imaging and cryopreservation equipment for livestock and companion animals
6.10%
Rolled out digital breeding management platform, expanded manufacturing in India
US$ 240.00 Million
6
B. Braun VetCare GmbH
Europe, North America, Middle East
Melsungen, Germany
Infusion therapy, surgical instruments, hospital-grade disposables for animals
5.90%
Introduced next-gen veterinary infusion pumps, strengthened OEM partnerships with clinic chains
US$ 230.00 Million
7
Midmark Animal Health
North America, Europe
Dayton, USA
Dental units, anesthesia and monitoring equipment, exam room solutions
5.40%
Enhanced ergonomic equipment lines, launched integrated workflow packages for mid-size clinics
US$ 210.00 Million
8
Esaote S.p.A. (Veterinary Segment)
Europe, Asia Pacific, Latin America
Genoa, Italy
Veterinary ultrasound and MRI systems
4.90%
Released portable ultrasound tailored to equine and companion practices, expanded distributor network
US$ 190.00 Million
9
Mindray Animal Medical
Asia Pacific, Latin America, Eastern Europe
Shenzhen, China
Patient monitoring, anesthesia, imaging systems for veterinary applications
4.60%
Aggressive pricing in emerging markets, introduced cloud-connected monitoring platform
US$ 180.00 Million
10
Smiths Medical Veterinary (ICU Medical)
North America, Europe, Middle East
Minneapolis, USA
Critical care, infusion and respiratory devices for animals
4.10%
Adapted human ICU technologies for veterinary use, focused on referral hospital partnerships
US$ 160.00 Million

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

Zoetis Inc.

Zoetis Inc. is a diversified animal health leader with a fast-growing portfolio of connected animal medical devices and integrated services.

Key Financials: 2025 Animal Medical Devices revenue US$ 720.00 Million; segment CAGR 2025-2032 estimated at 9.20%.
Flagship Products: Vetscan VS-Pro Monitors, TruFusion Vet Infusion Systems, VetGuardian Remote Monitoring Suite
2025-2026 Actions: Acquired a specialized veterinary surgery device firm and scaled remote monitoring pilots across major U.S. clinic networks.
Three-line SWOT: Extensive global commercial footprint and brand recognition; Dependence on developed markets for premium devices; Opportunity—cross-selling devices through strong pharmaceutical channels.
Notable Customers: Banfield Pet Hospital, VCA Animal Hospitals, Independent veterinary group practices
2

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. focuses on diagnostics-centric ecosystems, integrating hardware, software, and services for high-throughput veterinary practices globally.

Key Financials: 2025 Animal Medical Devices revenue US$ 640.00 Million; R&D intensity approximately 7.80% of total company revenue.
Flagship Products: Catalyst One Chemistry Analyzer, ProCyte One Hematology Analyzer, DR Digital Imaging Systems
2025-2026 Actions: Expanded AI-enabled imaging, bundled devices with cloud software subscriptions, and enhanced upgrade pathways for installed analyzers.
Three-line SWOT: Deep installed base and software stickiness; Premium pricing limits penetration in low-income markets; Opportunity—hardware-as-a-service models for mid-tier clinics.
Notable Customers: Corporate veterinary chains in North America, Independent small animal clinics, Reference laboratories
3

Covetrus (Animal Health Device Segment)

Covetrus operates a broad distribution and services platform, offering an expanding line of private-label animal medical devices to veterinary customers.

Key Financials: 2025 Animal Medical Devices revenue US$ 410.00 Million; operating margin in devices segment around 13.40%.
Flagship Products: Covetrus Vet Infusion Line, Covetrus Anesthesia Workstations, Covetrus Dental Systems
2025-2026 Actions: Integrated financing, logistics, and device supply; expanded private-label SKUs and negotiated exclusive clinic agreements.
Three-line SWOT: Strong distribution reach and customer relationships; Lower technology differentiation versus pure-play innovators; Opportunity—leveraging data to optimize clinic purchasing.
Notable Customers: Small and mid-size veterinary practices, Buying groups, Corporate veterinary networks
4

Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC combines pharmaceuticals with specialized surgical and pain management devices serving advanced companion animal procedures.

Key Financials: 2025 Animal Medical Devices revenue US$ 260.00 Million; devices revenue share about 16.00% of total company turnover.
Flagship Products: Dechra Vet Infusion Platform, OrthoVet Surgical Instrument Line, Dechra Pain Management Pump
2025-2026 Actions: Invested in smart infusion pumps, expanded surgeon training academies, and strengthened key opinion leader relationships in Europe.
Three-line SWOT: Strong reputation in veterinary surgery and pain care; Limited scale in North America devices; Opportunity—bundling drugs with smart delivery systems.
Notable Customers: Referral veterinary hospitals, Specialist surgical centers, European companion animal clinics
5

IMV Technologies Group

IMV Technologies Group is a specialist in reproductive technologies and associated devices for livestock, companion animals, and equine segments worldwide.

Key Financials: 2025 Animal Medical Devices revenue US$ 240.00 Million; livestock reproduction segment CAGR projected at 8.80% to 2032.
Flagship Products: AlphaVision Imaging Systems, QwikCheck Semen Analyzers, IMV CryoPreservation Tanks
2025-2026 Actions: Rolled out digital breeding management suite, expanded Asian manufacturing, and deepened partnerships with breeding cooperatives.
Three-line SWOT: Unique leadership in animal reproduction devices; Exposure to cyclical livestock cycles; Opportunity—precision breeding and genetics integration.
Notable Customers: Artificial insemination centers, Livestock producers, Equine reproduction clinics
6

B. Braun VetCare GmbH

B. Braun VetCare GmbH adapts human hospital-grade infusion and surgical technologies for veterinary clinics and animal hospitals globally.

Key Financials: 2025 Animal Medical Devices revenue US$ 230.00 Million; estimated EBITDA margin approximately 15.60% in veterinary segment.
Flagship Products: VetCare Infusomat Pumps, VetCare Surgical Instrument Sets, VetCare Safety IV Systems
2025-2026 Actions: Introduced smart infusion devices, optimized distribution partnerships, and promoted standardized safety protocols for animal infusions.
Three-line SWOT: High-quality, trusted human healthcare heritage; Less agility in small-practice customization; Opportunity—premiumization in referral and teaching hospitals.
Notable Customers: Veterinary teaching hospitals, Multispecialty animal hospitals, Larger group practices
7

Midmark Animal Health

Midmark Animal Health delivers integrated exam room, dental, and anesthesia equipment solutions tailored to workflow efficiency in veterinary clinics.

Key Financials: 2025 Animal Medical Devices revenue US$ 210.00 Million; capital equipment replacement cycle average 7.50 years.
Flagship Products: Midmark VetPro Dental Units, Midmark Matrx Anesthesia Machines, Midmark Monitoring Solutions
2025-2026 Actions: Optimized ergonomic designs, offered turnkey clinic build-out packages, and expanded service contracts across North America.
Three-line SWOT: Strong brand in practice equipment and ergonomics; Limited imaging portfolio; Opportunity—bundled exam room modernization projects.
Notable Customers: Small animal clinics, Dental-focused veterinary practices, New-build veterinary facilities
8

Esaote S.p.A. (Veterinary Segment)

Esaote S.p.A. serves the veterinary imaging niche with specialized ultrasound and MRI solutions for companion and equine practices.

Key Financials: 2025 Animal Medical Devices revenue US$ 190.00 Million; imaging-focused revenue mix above 85.00%.
Flagship Products: MyLab Vet Ultrasound Series, O-scan Vet MRI Systems, Portable Equine Ultrasound Platform
2025-2026 Actions: Released portable ultrasound, expanded training programs, and pursued OEM partnerships with veterinary practice groups.
Three-line SWOT: Deep imaging specialization and strong clinical image quality; Narrower product scope beyond imaging; Opportunity—portable devices in field-based equine medicine.
Notable Customers: Equine hospitals, Advanced imaging centers, Companion animal specialty clinics
9

Mindray Animal Medical

Mindray Animal Medical leverages its human medical technology base to offer cost-effective monitoring and imaging devices for veterinary use.

Key Financials: 2025 Animal Medical Devices revenue US$ 180.00 Million; double-digit revenue growth above 11.20% annually in emerging markets.
Flagship Products: Mindray Vet Monitoring Series, Mindray Vet Anesthesia Systems, Mindray Vet Ultrasound
2025-2026 Actions: Expanded cloud-connected monitoring, intensified price-competitive bids in Asia and Latin America, and localized training centers.
Three-line SWOT: Cost-competitive portfolio and rapid innovation cycles; Perceived as value brand in premium segments; Opportunity—device connectivity for multi-clinic groups.
Notable Customers: Emerging market veterinary hospitals, Budget-conscious clinics, Regional distributor networks
10

Smiths Medical Veterinary (ICU Medical)

Smiths Medical Veterinary translates critical-care infusion and respiratory expertise into devices tailored for high-acuity animal patients.

Key Financials: 2025 Animal Medical Devices revenue US$ 160.00 Million; critical-care portfolio accounts for roughly 70.00% of segment sales.
Flagship Products: Vetivex Infusion Systems, Veterinary ICU Ventilators, Critical-Care Monitoring Platforms
2025-2026 Actions: Adapted human ICU platforms to veterinary indications, focused on specialty referrals, and increased training on intensive care protocols.
Three-line SWOT: Strong positioning in critical care; Smaller footprint in general practice equipment; Opportunity—growing demand for advanced ICU-level animal care.
Notable Customers: Veterinary ICUs, Specialty and emergency hospitals, University veterinary centers

SWOT Leaders

Zoetis Inc.

SWOT Snapshot

SWOT
Strengths

Global commercial infrastructure, broad portfolio, strong brand equity, and deep integration with pharmaceutical offerings.

Weaknesses

High reliance on premium-priced products and complexity in integrating diverse acquisitions across regions.

Opportunities

Scaling connected monitoring, leveraging data services, and expanding into underpenetrated emerging markets and livestock segments.

Threats

Intensifying competition from lower-cost Asian vendors and shifting reimbursement or clinic budgeting pressures.

IDEXX Laboratories, Inc.

SWOT Snapshot

SWOT
Strengths

Large installed base of analyzers, strong software ecosystem, high switching costs, and robust innovation capabilities.

Weaknesses

Premium pricing and concentration in developed markets limit reach among smaller, resource-constrained practices.

Opportunities

Subscription-based models, AI-powered diagnostics, and expansion of integrated platforms in Asia Pacific and Latin America.

Threats

Emerging cloud-native diagnostic competitors and potential regulatory changes impacting data usage and connectivity.

Covetrus (Animal Health Device Segment)

SWOT Snapshot

SWOT
Strengths

Extensive distribution network, close clinic relationships, and growing private-label animal medical device portfolio.

Weaknesses

Lower technology differentiation and dependence on third-party OEMs for some high-end product categories.

Opportunities

Data-driven procurement optimization, financing solutions, and expanded exclusive supply agreements with clinic groups.

Threats

Disintermediation by direct-to-clinic manufacturers and consolidation among large veterinary chains negotiating harder terms.

Animal Medical Devices Market Regional Competitive Landscape

North America remains the largest revenue contributor, driven by high companion animal spend, dense clinic networks, and rapid adoption of advanced monitoring and imaging. Zoetis Inc., IDEXX Laboratories, and Midmark Animal Health dominate premium segments, while Covetrus leverages distribution scale to position private-label Animal Medical Devices market companies competitively.

Europe shows strong demand for surgical, infusion, and imaging devices, underpinned by stringent welfare regulations and advanced veterinary education. Dechra Pharmaceuticals PLC, B. Braun VetCare GmbH, Esaote, and Zoetis compete closely, with Animal Medical Devices market companies focusing on integrated training, high safety standards, and sustainability-aligned product designs.

Asia Pacific is the fastest-growing region, supported by expanding middle-class pet ownership and modernization of livestock production. Mindray Animal Medical, IMV Technologies Group, and global Animal Medical Devices market companies invest heavily in localized manufacturing, tiered pricing, and distributor partnerships to capture clinics in China, India, and Southeast Asia.

Latin America presents rising opportunities in both companion and production animals, especially in Brazil and Mexico. IMV Technologies Group leads reproductive devices, while Zoetis and IDEXX expand diagnostic and monitoring footprints. Animal Medical Devices market companies increasingly bundle devices with herd health services and financing to address budget constraints.

The Middle East and Africa remain smaller but high-potential markets, characterized by growing referral hospitals and equine centers. B. Braun VetCare GmbH, Smiths Medical Veterinary, and select Animal Medical Devices market companies target critical care and high-acuity procedures, often supplying premium imports to flagship facilities and university hospitals.

Animal Medical Devices Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

VetSense AI
Disruptor
USA

Develops AI-enhanced, cloud-connected veterinary monitoring devices that integrate predictive analytics into clinic workflows for early deterioration detection.

AnimaTech Diagnostics
Disruptor
Germany

Offers compact, cartridge-based point-of-care analyzers designed specifically for small clinics seeking lower-cost alternatives to incumbent analyzers.

PawMetrics Health
Disruptor
United Kingdom

Provides wearable vital-sign sensors for companion animals, bridging home monitoring with clinic platforms via subscription-based device services.

AgriVet Devices
Disruptor
India

Focuses on rugged, low-cost livestock infusion and reproductive devices tailored for farm conditions in emerging markets and cooperative networks.

EquiScan Imaging
Disruptor
France

Specializes in portable equine imaging systems, enabling advanced diagnostics at racetracks and field practices with lightweight, battery-powered units.

Animal Medical Devices Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Animal Medical Devices market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Animal Medical Devicesmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.